Table 1. Chronic Metabolic Disease Drug Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Chronic Metabolic Disease Drug Market Restraints

Table 3. Chronic Metabolic Disease Drug Market Trends

Table 4. Chronic Metabolic Disease Drug Industry Policy

Table 5. Global Chronic Metabolic Disease Drug Revenue by Company, 2018-2023, US$ million

Table 6. Global Chronic Metabolic Disease Drug Revenue Market Share by Company, 2018-2023

Table 7. Global Chronic Metabolic Disease Drug Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global Chronic Metabolic Disease Drug Sales Volume Market Share by Company, 2018-2023

Table 9. Global Chronic Metabolic Disease Drug Price by Company, 2018-2023, (US$/Unit)

Table 10. Global Chronic Metabolic Disease Drug Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Chronic Metabolic Disease Drug Mergers & Acquisitions, Expansion Plans

Table 12. Global Chronic Metabolic Disease Drug Manufacturers Product Type

Table 13. China Chronic Metabolic Disease Drug Revenue by Company, 2018-2023, US$ million

Table 14. China Chronic Metabolic Disease Drug Revenue Market Share by Company, 2018-2023

Table 15. China Chronic Metabolic Disease Drug Sales Volume by Company, 2018-2023, (K Units)

Table 16. China Chronic Metabolic Disease Drug Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, Chronic Metabolic Disease Drug Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China Chronic Metabolic Disease Drug Import & Export Trends

Table 19. Main Sources of China Chronic Metabolic Disease Drug Import

Table 20. Export Destination of China Chronic Metabolic Disease Drug

Table 21. Global Headquarters and Manufacturing Base of Chronic Metabolic Disease Drug Manufacturers

Table 22. Global Major Manufacturers, Chronic Metabolic Disease Drug Capacity Expansion and Future Plans

Table 23. Global Chronic Metabolic Disease Drug Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global Chronic Metabolic Disease Drug Production by Region, 2018-2023, (K Units)

Table 25. Global Chronic Metabolic Disease Drug Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Chronic Metabolic Disease Drug Upstream (Raw Materials)

Table 27. Global Chronic Metabolic Disease Drug Typical Customers

Table 28. Chronic Metabolic Disease Drug Typical Distributors

Table 29. By Type, Global Chronic Metabolic Disease Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global Chronic Metabolic Disease Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global Chronic Metabolic Disease Drug Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global Chronic Metabolic Disease Drug Revenue, 2018-2029, US$ Million

Table 33. By Region, Global Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global Chronic Metabolic Disease Drug Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global Chronic Metabolic Disease Drug Revenue, 2018-2029, US$ Million

Table 36. By Country, Global Chronic Metabolic Disease Drug Revenue Market Share, 2018-2029

Table 37. By Country, Global Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global Chronic Metabolic Disease Drug Sales Volume Market Share, 2018-2029

Table 39. Novartis Company Information, Head Office, Market Area and Industry Position

Table 40. Novartis Chronic Metabolic Disease Drug Models, Specifications and Application

Table 41. Novartis Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Novartis Company Profile and Main Business

Table 43. Novartis Recent Developments

Table 44. Daiichi Sankyo Company Information, Head Office, Market Area and Industry Position

Table 45. Daiichi Sankyo Chronic Metabolic Disease Drug Models, Specifications and Application

Table 46. Daiichi Sankyo Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Daiichi Sankyo Company Profile and Main Business

Table 48. Daiichi Sankyo Recent Developments

Table 49. Actelion Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 50. Actelion Pharmaceuticals Chronic Metabolic Disease Drug Models, Specifications and Application

Table 51. Actelion Pharmaceuticals Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Actelion Pharmaceuticals Company Profile and Main Business

Table 53. Actelion Pharmaceuticals Recent Developments

Table 54. Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position

Table 55. Boehringer Ingelheim Chronic Metabolic Disease Drug Models, Specifications and Application

Table 56. Boehringer Ingelheim Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Boehringer Ingelheim Company Profile and Main Business

Table 58. Boehringer Ingelheim Recent Developments

Table 59. Eli Lilly Company Information, Head Office, Market Area and Industry Position

Table 60. Eli Lilly Chronic Metabolic Disease Drug Models, Specifications and Application

Table 61. Eli Lilly Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Eli Lilly Company Profile and Main Business

Table 63. Eli Lilly Recent Developments

Table 64. Fresenius Kabi Company Information, Head Office, Market Area and Industry Position

Table 65. Fresenius Kabi Chronic Metabolic Disease Drug Models, Specifications and Application

Table 66. Fresenius Kabi Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Fresenius Kabi Company Profile and Main Business

Table 68. Fresenius Kabi Recent Developments

Table 69. Torrent Labs Company Information, Head Office, Market Area and Industry Position

Table 70. Torrent Labs Chronic Metabolic Disease Drug Models, Specifications and Application

Table 71. Torrent Labs Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Torrent Labs Company Profile and Main Business

Table 73. Torrent Labs Recent Developments

Table 74. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 75. Pfizer Chronic Metabolic Disease Drug Models, Specifications and Application

Table 76. Pfizer Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Pfizer Company Profile and Main Business

Table 78. Pfizer Recent Developments

Table 79. Novo Nordisk Company Information, Head Office, Market Area and Industry Position

Table 80. Novo Nordisk Chronic Metabolic Disease Drug Models, Specifications and Application

Table 81. Novo Nordisk Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Novo Nordisk Company Profile and Main Business

Table 83. Novo Nordisk Recent Developments

Table 84. AstraZeneca plc Company Information, Head Office, Market Area and Industry Position

Table 85. AstraZeneca plc Chronic Metabolic Disease Drug Models, Specifications and Application

Table 86. AstraZeneca plc Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. AstraZeneca plc Company Profile and Main Business

Table 88. AstraZeneca plc Recent Developments

Table 89. Regeneron Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 90. Regeneron Pharmaceuticals Chronic Metabolic Disease Drug Models, Specifications and Application

Table 91. Regeneron Pharmaceuticals Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 92. Regeneron Pharmaceuticals Company Profile and Main Business

Table 93. Regeneron Pharmaceuticals Recent Developments

Table 94. GlaxoSmithKline plc Company Information, Head Office, Market Area and Industry Position

Table 95. GlaxoSmithKline plc Chronic Metabolic Disease Drug Models, Specifications and Application

Table 96. GlaxoSmithKline plc Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 97. GlaxoSmithKline plc Company Profile and Main Business

Table 98. GlaxoSmithKline plc Recent Developments

Table 99. Merck & Co. Inc Company Information, Head Office, Market Area and Industry Position

Table 100. Merck & Co. Inc Chronic Metabolic Disease Drug Models, Specifications and Application

Table 101. Merck & Co. Inc Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 102. Merck & Co. Inc Company Profile and Main Business

Table 103. Merck & Co. Inc Recent Developments

List of Figure

Figure 1. Chronic Metabolic Disease Drug Picture

Figure 2. By Revenue, Global Chronic Metabolic Disease Drug Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global Chronic Metabolic Disease Drug Market Size and Forecast, 2018-2029, (K Units)

Figure 4. Global Chronic Metabolic Disease Drug Price Trend, 2018-2029, (US$/Unit)

Figure 5. By Revenue, China Chronic Metabolic Disease Drug Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China Chronic Metabolic Disease Drug Market Size and Forecast, 2018-2029, (K Units)

Figure 7. China Chronic Metabolic Disease Drug Price Trend, 2018-2029 (US$/Unit)

Figure 8. By Revenue, China Chronic Metabolic Disease Drug Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China Chronic Metabolic Disease Drug Share of Global Market, 2018-2029

Figure 10. Global Chronic Metabolic Disease Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Chronic Metabolic Disease Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Chronic Metabolic Disease Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Chronic Metabolic Disease Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Chronic Metabolic Disease Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of Chronic Metabolic Disease Drug Domestic VS Export, 2022

Figure 16. Global Chronic Metabolic Disease Drug Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global Chronic Metabolic Disease Drug Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Chronic Metabolic Disease Drug Production Market Share & Forecast by Region, 2018-2029

Figure 19. Chronic Metabolic Disease Drug Industry Chain

Figure 20. Chronic Metabolic Disease Drug Procurement Model

Figure 21. Chronic Metabolic Disease Drug Sales Model

Figure 22. Chronic Metabolic Disease Drug Sales Channels, Direct Sales and Distribution

Figure 23. Hypertension Drug

Figure 24. Hyperlipidemia Drug

Figure 25. High Blood Sugar Drug

Figure 26. High Uric Acid Drug

Figure 27. By Type, Global Chronic Metabolic Disease Drug Revenue, 2018-2029, US$ Million

Figure 28. By Type, Global Chronic Metabolic Disease Drug Revenue Market Share, 2018-2029

Figure 29. By Type, Global Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)

Figure 30. By Type, Global Chronic Metabolic Disease Drug Sales Volume Market Share, 2018-2029

Figure 31. By Type, Global Chronic Metabolic Disease Drug Price, 2018-2029, (US$/Unit)

Figure 32. Hospital

Figure 33. Clinic

Figure 34. Others

Figure 35. By Application, Global Chronic Metabolic Disease Drug Revenue, 2018-2029, US$ Million

Figure 36. By Application, Global Chronic Metabolic Disease Drug Revenue Market Share, 2018-2029

Figure 37. By Application, Global Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)

Figure 38. By Application, Global Chronic Metabolic Disease Drug Sales Volume Market Share, 2018-2029

Figure 39. By Application, Global Chronic Metabolic Disease Drug Price, 2018-2029, (US$/Unit)

Figure 40. By Region, Global Chronic Metabolic Disease Drug Revenue Market Share, 2018-2029

Figure 41. By Region, Global Chronic Metabolic Disease Drug Sales Volume Market Share, 2018-2029

Figure 42. North America Chronic Metabolic Disease Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 43. By Country, North America Chronic Metabolic Disease Drug Revenue Market Share, 2022

Figure 44. Europe Chronic Metabolic Disease Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 45. By Country, Europe Chronic Metabolic Disease Drug Revenue Market Share, 2022

Figure 46. Asia Pacific Chronic Metabolic Disease Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 47. By Country/Region, Asia Pacific Chronic Metabolic Disease Drug Revenue Market Share, 2022

Figure 48. South America Chronic Metabolic Disease Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 49. By Country, South America Chronic Metabolic Disease Drug Revenue Market Share, 2022

Figure 50. Middle East & Africa Chronic Metabolic Disease Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 51. U.S. Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)

Figure 52. By Company, U.S. Chronic Metabolic Disease Drug Market Share, 2022

Figure 53. By Type, U.S. Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029

Figure 54. By Application, U.S. Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029

Figure 55. Europe Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)

Figure 56. By Company, Europe Chronic Metabolic Disease Drug Market Share, 2022

Figure 57. By Type, Europe Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029

Figure 58. By Application, Europe Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029

Figure 59. China Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)

Figure 60. By Company, China Chronic Metabolic Disease Drug Market Share, 2022

Figure 61. By Type, China Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029

Figure 62. By Application, China Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029

Figure 63. Japan Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)

Figure 64. By Company, Japan Chronic Metabolic Disease Drug Market Share, 2022

Figure 65. By Type, Japan Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029

Figure 66. By Application, Japan Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029

Figure 67. South Korea Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)

Figure 68. By Company, South Korea Chronic Metabolic Disease Drug Market Share, 2022

Figure 69. By Type, South Korea Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029

Figure 70. By Application, South Korea Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029

Figure 71. Southeast Asia Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)

Figure 72. By Company, Southeast Asia Chronic Metabolic Disease Drug Market Share, 2022

Figure 73. By Type, Southeast Asia Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029

Figure 74. By Application, Southeast Asia Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029

Figure 75. India Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)

Figure 76. By Company, India Chronic Metabolic Disease Drug Market Share, 2022

Figure 77. By Type, India Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029

Figure 78. By Application, India Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029

Figure 79. Middle East & Asia Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)

Figure 80. By Company, Middle East & Asia Chronic Metabolic Disease Drug Market Share, 2022

Figure 81. By Type, Middle East & Asia Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029

Figure 82. By Application, Middle East & Asia Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029

Figure 83. Research Methodology

Figure 84. Breakdown of Primary Interviews

Figure 85. Bottom-up Approaches

Figure 86. Top-down Approaches